<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE164413" accession="SRP300809">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP300809</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA690568</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE164413</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>RNAseq in JARID2 siRNA-treated in vitro differentiated human primary adipocytes</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>RNAseq was performed in siJARID2 and control siRNA-treated human adipose tissue derived stem cells (hASC). The tretment of siRNA was performed by electroporation one day before induction of differentiation in vitro. The cells were lyzed and RNA was purified on day 6 (mid differentiation) and day 13 (full differentiation) from differentiation start. Overall design: RNAseq was performed in siJARID2 and control siRNA-treated human adipose tissue derived stem cells (hASC). The tretment of siRNA was performed by electroporation one day before induction of differentiation in vitro. The cells were lyzed and RNA was purified on day 6 (mid differentiation) and day 13 (full differentiation) from differentiation start. Three independen experiments were analyzed for both day 6 (transfections HG23, HG23_2, HG24) and day 13 (transfections TRANSF2,3,4). Samples of negative  control (non-targeting siRNA) and siJARID2 from the same experiment were anayzed as paired samples.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE164413</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
    <STUDY_LINKS>
      <STUDY_LINK>
        <XREF_LINK>
          <DB>pubmed</DB>
          <ID>33963396</ID>
        </XREF_LINK>
      </STUDY_LINK>
    </STUDY_LINKS>
  </STUDY>
</STUDY_SET>
